Tag: PAD

Surmodics announces first patient uses of two Sublime radial access platform...

Surmodics recently announced the successful first uses in patients for two devices within its Sublime radial access platform: the Sublime radial access guide sheath and...

Study identifies ‘critical need’ for guidelines on appropriate use of atherectomy

No data currently exist to support the use of atherectomy over other procedures for the treatment of peripheral arterial disease (PAD), and the healthcare...

SVS SET: PAD patient walks away from pain

Ice, cold and snow make it tough to walk outside in Lansing, Michigan, right now. So, jokes Doug Giller, he is wearing a path...

Coaches ‘integral’ to SVS SET app program

“A good coach will make his players see what they can be rather than what they are.” Those are words ascribed to football coach...

Supervised Exercise Therapy: There’s an app for that

Call it timing on several fronts, each part coming together for the benefit of patients with peripheral arterial disease (PAD). Included in the mix was...

Postmarket study of sirolimus-eluting balloon enrolls first patient

MedAlliance has announced enrollment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon Selution SLR for the treatment...

Veterans study: No evidence of increased risk of death with use...

A study of more than 10,000 U.S. veterans with peripheral arterial disease (PAD) undergoing endovascular interventions in the femoropopliteal segment found that rates of...

How to succeed in vascular surgery: A guide for the aspiring...

Disclaimer: The views expressed here do not reflect those of Mayo Clinic, the Society for Vascular Surgery, Vascular Specialist, or even the author, for...

Walking can relieve leg pain in people with PAD

Exercise can play an important role in treating peripheral arterial disease (PAD), a recent review by Amy Harwood, PhD, from the Centre for Sport and...

Target 2021: SVS councils and committees drill down on key goals...

While there is little doubt the pandemic has impacted each vascular surgeon and the SVS as a Society in numerous ways, the commitment and...

‘Successful’ first-in-human use of the Efemoral scaffold system announced

Efemoral Medical has announced the first-in-human (FIH) use of the company’s Efemoral Vascular scaffold system (EVSS) with FlexStepv technology in the EFEMORAL I FIH...

WIfI score found to be accurate across racial groups

The wound, ischemia and foot infection (WIfI) score is as accurate a predictor of risk for limb loss in Black people as it is...

Revascularization ‘improves’ walking performance in claudicating PAD patients 

Revascularization of the lower extremity improves hemodynamics, walking performance, quality of life and calf-muscle pathology in claudicating patients with peripheral arterial disease (PAD), researchers...

VOYAGER PAD: Rivaroxaban plus aspirin versus aspirin alone among CLTI patients...

In one of the latest sub-analyses from the VOYAGER PAD trial, investigators found that rivaroxaban plus aspirin versus aspirin alone in the high-risk population...

Previously described patient-centered clinical success measure after revascularization for diabetic foot...

Patient-centered clinical success after lower-extremity revascularization for people with diabetic foot wounds was achieved among 63% of patients in a new analysis—but researchers suggest...

Intravascular lithotripsy superior to PTA in acute procedural success out to...

The DISRUPT PAD III randomized controlled trial (RCT) provides the largest level-one evidence for the treatment of heavily calcified femoropopliteal arteries, noted William Gray,...

Latest VOYAGER PAD analysis finds no mortality and improved limb outcomes...

Given the absence of a safety signal in data from the VOYAGER PAD trial, a new analysis examined the potential benefit of drug-coated device...

Utilize new SVS Branding Toolkit

The new SVS Branding Toolkit—a robust set of tools designed to help members communicate their roles in comprehensive vascular care—is now available exclusively and...

Janssen applies to FDA for new indication to expand use of...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the Food and Drug...

New analysis finds DCBs lead to greater four-year survival after fempop...

Patients treated with a paclitaxel-coated balloon saw greater survival, freedom from amputation and amputation-free survival through four-year follow-up after their initial femoropopliteal revascularization operation...

Hodgson: Bringing appropriateness into sharper focus

In 2019, Kim Hodgson, MD, kicked off his presidential year by placing appropriateness and quality of care under the microscope. His turn organizing the...

Vascular Specialist–October 2020

In this issue: Special interview: Kim Hodgson, MD, discusses his SVS presidency, his appropriateness-in-care agenda, the new SVS SET app, and his post-presidential priorities...

VA system delivers high quality services for veterans

Vascular surgery in the Veterans Health Administration has always been a robust service, developing into a mature specialty around the time of the Vietnam...

‘No signal of increased risk of long-term mortality’ with paclitaxel-coated Luminor...

An ad hoc, two-year analysis of the EffPac study found no signal of increased risk of long-term mortality, nor any adverse events, within two years...

Disproportionately more women are affected by depression when pursuing specialty PAD...

A disproportionately higher percentage of women are affected by depressive symptoms when they seek specialty care for new or worsening peripheral arterial disease (PAD)...

High level of heterogeneity found in randomized PAD trial antithrombotic regimens

A recent systematic review showed that randomized trials comparing different types of peripheral endovascular arterial intervention have a high level of heterogeneity in their...

Diversity, equity and inclusion: Disparities in medicine and vascular surgery

Recent months have yielded a conversation on systemic racism perhaps unlike any other before. We’ve learned about how it manifests across society, how it...

‘If I had gone along the path advised, I would never...

Some of the formative educational experiences described by Olamide Alabi, MD, read like textbook examples of the subtleties many see as baked into U.S....

Doubted as a doctor during mid-flight medical emergency and once asked:...

In a vascular surgery career spanning 20 years, Vincent Rowe, MD, has seen it all: Tending to patients at bedside, the vascular surgical services...

‘Casting a wider net’ when researching genetic and molecular factors of...

For vascular surgeon and research scientist Elsie Gyang Ross, MD, the world of data science might hold some of the answers to the kind...

‘Improving disparities in healthcare is not a matter of slapping some...

Andrew Gonzalez, MD, had a heart for underserved and under- resourced communities embedded early. The son of a pediatric hematologist mother who worked at...

Black patients in areas with lowest PAD rates disproportionally at higher...

It’s among the most topical areas of discussion in current U.S. cultural life: Black people face disparities in terms of healthcare outcomes. And the...

SVN to host virtual annual meeting July 15

The Society for Vascular Nursing (SVN) 38th Annual Conference—a virtual meeting—will be held from 6 to 9:30 p.m. Central Daylight Time Wednesday, July 15. In...

International Lecture: Endovascular colossus discusses new PAD therapy

A new therapy of hydration and oncotic pressure of plasma helped 100% of certain elderly peripheral artery disease (PAD) patients in terms of pain,...

SVS pilots SET app for peripheral artery disease patients

Doctor-prescribed and -supervised exercise therapy is going digital. The Society for Vascular Surgery (SVS) will begin piloting a ground-breaking app for Supervised Exercise Therapy...

SVS in transition: A look back, a look ahead

Each Society for Vascular Surgery (SVS) president wishes for a memorable annual meeting, outgoing SVS president Kim Hodgson, MD, noted during his State of...

TOBA III clinical trial results published

Intact Vascular has announced the peer-reviewed publication of its Tack optimized balloon angioplasty (TOBA) III 12-month clinical trial results in the Journal of Vascular Surgery. The multi-center, single-arm,...

Technology drives vascular future

Decades ago, “picture” phones were an idea straight out of science fiction. As the saying goes, the future is now. FaceTime and Skype are...

Quality: Global Vascular Guidelines pocket guide coming soon

The Global Vascular Guidelines (GVG), extensively researched and written by an international committee of leading vascular experts, will soon be available as a pocket...

Clopidogrel exposure along with aspirin and rivaroxaban should be ‘minimized or...

“More bleeding with background clopidogrel, even if not severe by adjudication, may be associated with broad consequences, including discontinuation of therapies. In the absence...

Combining aspirin with rivaroxaban reduces risk equally in presence or absence...

In stable atherosclerosis, a combination of aspirin plus rivaroxaban provided a similar relative degree of benefit on coronary, cerebrovascular and peripheral endpoints in patients...

Aspirin plus rivaroxaban significantly lowers adverse events in PAD revascularization

Treatment with aspirin plus rivaroxaban following lower-extremity revascularization in patients with peripheral arterial disease (PAD) leads to a 15% reduction in the risk of...